• Ornithine transcarbamylase IOTCI deficiency is an X chromosome-linked disorder causing hyperammonemic encephalopathy with a very poor prognosis. We describe here two patients with OTe deficiency. one a late-onset female patient lease 11 and the other a neonatal-onset male patient (case 2). who were successfully treated with orthotopic live, transplantation IOLTxl. The OTC activity in the excised liver was 10% and 0 % of control. respectively. Hyperammonemic encephalopathy was controlled with medical therepy in case 1 until the age of 5 years. but the complicated course in case 2 in which hyperammonemia required peritoneal dialysis and hemodialysis in the neonatal period necessitated OL Tx with a reduced-size liver at the age of 80 days. Both patients had restoration of serum ammonia level to normal in 2 and 3 days after liver replacement, and both patients have normal neurological and developmental status after 2 and 0.5 years of postoperative follow-up. These cases illustrate not only the metabolic cure of this disorder, but also the need to preserve neurological integrity by aggressive medical management of the hyperammonemia preoperatively and early surgical intervention when indicated. even if this is required very early in life.
O

RNITHINE transcarbamylase (OTC) deficiency
is an X chromosome-linked disorder that causes hyperammonemia and elevated blood glutamine levclS. I - 4 The acute development of these metabolic abnormalities causes brain edema. which often progresses to coma and death. I·" Patients with urea cycle enzyme abnormalities including OTC deficiency have undergone liver transplantation as a substitutive treatment for medical therapy.l.s. 7 .s This article describes two cases of OTC deficiency with hyperammonemic encephalopathy that were successfully treated with orthotopic liver transplantation.
CASE REPORTS
Case J
A girl wilh an uncomplicated gestallon and delivery presented wilh vomltang and feeding intolerance at aboul 3 weeks of age. Her ammonia h:vd was elevated to 337 ILmoi/L which could be controllc:d by protean restriction. At the age of I year. serum amano a~id analysis showed an elevated glutamine level. Despite treatment with benzoate. citrulline. and carnnine. she experienced penodic episodes of hyperammonemlc encephalopathy rangmg from lethargy to coma and was referred to our institution at the age of 5 years in July 1991. Her only presenting symptom was a mildly ataxic gait. Her ammonia level was 151 I-LmoltL. serum glutamine level was I08ILmoi/dL (control. 32 to 87I-Lmol/dL). She had a body weight of 26 kg. blood urea nitrogen less than 2mg/dL, and mildly elevated liver enzymes.
On July 17. 1991. she underwent orthotopic liver transplantation from a 6-year-old donor of identical blood type and body weight. using a piggy-back method~ and Roux-en-Y choledochojejunostomy. FK 506 (Tacrolimus: Fiujisawa Pharmaceutical Co. Osaka. Japan) and steroids were used as immunosuppressive agents. and the postoperative course was uneventful. From the resected native liver. OTC enzyme analysis showed a residual activity of about 10% (235 I-Lmol/h/g weight of liver: control. 2417 ILmolth/g weight of liver). Carbamyl phosphate synthetase I. arginosuccinate synthetase. arginosuccinase. and arginase enzyme activities were within normal ranges. Plasma ammonia levels returned to a normal range on the second postoperative day. She has had no neurological deficits. and after a 2-year follow-up. she is doing well without protein restriction and has normal development.
ease 2 A boy with a full-term uncomplicated delivery manifested symptoms of lethargy and decreased breast fceding frequency at around 24 hours of age. By J6 hours. he hegan vomiting with concomitant respiratory alkaillsis and an elevated ammonia level of 3341-LmollL. The serum glutamate level was elevated (28I-LmoildL; control. 0 to 10 ILmoildL) and citrulline was nondetectable. Urinary orolic acid was markedly elevated (173 IJ.moilmin creatinine: control. [) to 3 ILmolimin crealinine). From the liver biopsy performed at the age of 27 days. OTC enzyme a~tivity was completely nllndetectable. The other urea q'cle enzyme activities were normal. lie was placed on a low-prolem diet. benzoate. and phenylacetate_ Despite this therapy. epislIdic hyperammonemia developed. associated with severe lethargy. ,md peritoneal dialysis and hemodialysis were required. On October 2. 1993. he was Iransferred 10 our inslltution with an ammonia level of 130 IJ.moilL. His liver enzyme levels were slightly elevated. He was profoundly lethargic but with nll fllcal neurological deficits. All olher systems wac within normal range.
On October IS. 19tJ3. at the age of ISO days (hody weight 6 kg). he underwent orthotopic liver transplantation using a reduced-size lefllaterallobe liver graft from a 5-year-old 26 kg donor of identical hlood type_ The operation was performed using a piggy-back (ammonia 69 I1moI/L). his recovery was steady. By the third postoperative day. the ammonia level as well as his serum amino acids and urinary orotic acid levels returned to normal. A mild acute cellular rejection was treated with increased steroids. and a pleural effusion resolved with total parenteral nutrition. On 6·month follow-up. he has been well with no neurological or developmental impairment.
DISCUSSION
OTe deficiency is clinically classified into two groups, neonatal-onset male patients and late-onset female patients. We had one of each. Because the structural gene encoding for the OTe enzyme protein is located on the short arm of the X-chromosome, Xp 21,I,2 the homozygous male patient typically is completely enzyme deficient and subsequently has encephalopathy caused by hyperammonemia, which presents as irritability. poor feeding, vomiting. and lethargy. usually within the first week of life. 1 . 3 .5.6 These neonatal-onset patients have poor prognoses. 1·3.5.6 In contrast. the heterozygous female patient has a partial enzyme deficiency because of random inactivation of the X-chromosome caused by lyonization. 1 . J • 5 These patients have variable clinical symptoms that manifest later in life. occurring after 1 month of age, or possibly not at aI1. 1 • .1. 5 Our female patient (case 1) had partial enzyme deficiency with late-onset symptoms. whereas our male patient (case 2) completely lacked the OTC activity and consequently had acute onset of symptoms shortly after birth and required peritoneal dialysis and hemodialysis. despite which hyperammonemia was refractory to treatment.
A serum ammonia level greater than 200 ILmol/ L causes diffuse brain edema.~ With the rapid elevation of ammonia. irreversible brain edema and herniation develop. which invariably result in death without prompt intervention. l · n The initial medical therapy consists of protein restriction. benzoate. phenylac-I!tate. arginine. citrulline. pyridoxine. and folic acid administration. and peritoneal dialysis or hemodialysis.1.2.~.5 These therapies are burdensome and can have side etfects of developmental impairment secondary to malnutrition.~·5 Moreover. despite medical
